Hospitalized patients with complex dietary restrictions often develop hyperglycemia, or high blood sugar. This occurs in roughly one-quarter to one-half of these patients and can lead to serious ...

Please provide your email address to receive an email when new articles are posted on . Of 20 hospitals providing insulin algorithms, 60% stated which patients should initiate basal or nutritional ...

To address this, researchers created a self-adjusting subcutaneous insulin algorithm (SQIA) for use at UCSF’s San Francisco hospitals. A new study shows that their SQIA reduces rates of severe ...

Bigfoot Biomedical is doing its part to ensure that the possibility of building a smarter diabetes management system is more than just an urban legend. The tech maker has purchased a new algorithm ...

MILPITAS, Calif.--(BUSINESS WIRE)--Bigfoot Biomedical (Bigfoot), a leader in developing intelligent connected injection support systems, today announced the acquisition of a reinforcement learning ...

The Food and Drug Administration has cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for people six years of age and older with Type 1 diabetes. These two devices, along ...

Please provide your email address to receive an email when new articles are posted on . The FDA cleared the iLet ACE insulin pump and iLet dosing decision software for people with type 1 diabetes. The ...

There may be another leap toward an artificial pancreas thanks to new research released by Animas Corp. At the Advanced Technologies & Treatments for Diabetes Conference in February, the company, part ...

(MENAFN- GetNews) Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App: a strategic turning point. The company confirms its status as a global reference ...

Looking to the European market, digital therapeutics company Amalgam Rx has scored an E.U. CE Mark for its insulin titration algorithm, called iSage Rx, and its white-label variants. This comes more ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that its next-generation automated insulin delivery ...